Topic 10: Musculoskeletal System, Skin, And Subcutaneous Tissue

Lesson 10.1: Arthritis And Connective Tissue Disease

Official syllabus section covering Lesson 10.1: Arthritis and Connective Tissue Disease within Topic 10: Musculoskeletal System, Skin, and Subcutaneous Tissue: Osteoarthritis, rheumatoid arthritis, crystal arthropathies, and seronegative spondyloarthropathies.; Systemic connective tissue diseases and vasculitides..

Lesson 10.1: Arthritis and Connective Tissue Disease

Introduction

The musculoskeletal system comprises bones, joints, muscles, and connective tissues that allow us to move and support our body. This lesson focuses on arthritis and connected tissue diseases, specifically osteoarthritis, rheumatoid arthritis, crystal arthropathies, and seronegative spondyloarthropathies. Students will learn to differentiate between inflammatory and non-inflammatory types of arthritis, recognize systemic connective tissue diseases, and understand vasculitis.

Learning Objectives

  • Comprehend the pathophysiology of osteoarthritis, rheumatoid arthritis, crystal arthropathies, and seronegative spondyloarthropathies.
  • Identify systemic connective tissue diseases and vasculitis.
  • Differentiate inflammatory from non-inflammatory arthritis and determine appropriate treatments.
  • Recognize and explain common terminologies related to arthritis and connective tissue disease, including key concepts.

Section 1: Osteoarthritis

Osteoarthritis (OA) is the most common form of arthritis, characterized by the degeneration of joint cartilage and the underlying bone. It typically affects weight-bearing joints such as the knees, hips, and spine. The pathophysiology involves mechanical stress on joints leading to the breakdown of cartilage, inflammation, and ultimately bone changes.

Key Features and Symptoms

  • Age: Typically occurs in individuals aged 50 and over.
  • Symptoms: Pain during or after movement, stiffness, decreased range of motion, and crepitus (a crackling sound) during joint movement.

Diagnosis

Diagnosis of OA is primarily clinical but can be assisted by imaging studies. X-rays may show joint space narrowing, subchondral sclerosis, and osteophyte formation.

Treatment

Treatment options for OA include:

  • Non-Pharmacological: Weight management, physical therapy, and exercise.
  • Pharmacological: Acetaminophen, NSAIDs (non-steroidal anti-inflammatory drugs), and topical analgesics.
  • Surgical: Joint replacement surgery may be necessary in severe cases.

Example: Case Study on Osteoarthritis

Case: A 65-year-old female presents with knee pain that worsens with activity. Upon examination, there is tenderness and swelling around the knee joint, with decreased range of motion.

Step-by-Step Analysis:

  1. History: Obtain a thorough patient history regarding the onset, duration, and character of the pain.
  2. Physical Examination: Conduct an examination focusing on range of motion, tenderness, joint swelling, and the presence of crepitus.
  3. Imaging: Order an X-ray to evaluate for joint space narrowing and osteophytes.
  4. Diagnosis: Confirm the diagnosis of osteoarthritis based on symptoms and findings, and discuss treatment options.

Section 2: Rheumatoid Arthritis

Rheumatoid arthritis (RA) is an autoimmune disease that primarily affects the joints, causing chronic inflammation and potentially leading to joint destruction. The immune system mistakenly attacks the synovium, the lining of the membranes that surround joints.

Key Features

  • Age: Can occur at any age, but commonly starts between 30 and 60 years.
  • Symptoms: Symmetrical joint pain, morning stiffness lasting more than 30 minutes, fatigue, and systemic symptoms.

Diagnosis

Diagnosis involves a combination of clinical evaluation, laboratory tests including rheumatoid factor (RF) and anti-citrullinated protein antibody (ACPA) tests, and imaging to reveal joint erosions.

Treatment

  • Methotrexate is often the first-line treatment for RA, while other DMARDs (disease-modifying antirheumatic drugs) may also be employed.
  • Biologic agents like TNF inhibitors can be considered if traditional DMARDs are ineffective.

Example: Case Study on Rheumatoid Arthritis

Case: A 45-year-old male presents with joint pain in both wrists and hands that is worse in the morning.

Step-by-Step Analysis:

  1. History: Assess for duration and characteristics of joint symptoms and any potential family history of autoimmune diseases.
  2. Physical Examination: Inspect for bilateral joint swelling, tenderness, and deformities such as ulnar deviation.
  3. Laboratory Tests: Obtain blood tests for RF and ACPA.
  4. Imaging: X-ray may show joint erosions and soft tissue swelling.
  5. Diagnosis: Confirm RA diagnosis based on clinical findings and laboratory results, and begin treatment with methotrexate.

Section 3: Crystal Arthropathies

Crystal arthropathies are a group of diseases characterized by the deposition of crystals in joints, leading to inflammation. The most common types are gout, caused by urate crystals, and pseudogout, caused by calcium pyrophosphate crystals.

Key Features

  • Gout: Typically presents suddenly with intense joint pain, often in the big toe, and may be associated with hyperuricemia.
  • Pseudogout: Often affects the knee and is characterized by less acute severe pain compared to gout.

Diagnosis

Diagnosis involves joint aspiration and analysis of synovial fluid under polarized light to identify crystals.

Treatment

  • Gout: Treatments include NSAIDs, colchicine, and urate-lowering therapies like allopurinol.
  • Pseudogout: Often managed with NSAIDs or corticosteroids.

Example: Case Study on Gout

Case: A 50-year-old male experiences sudden severe pain in his right big toe.

Step-by-Step Analysis:

  1. History: Inquire about dietary habits, previous attacks, and family history of gout.
  2. Physical Examination: Check for redness and swelling in the affected toe.
  3. Joint Aspiration: Perform and analyze fluid for monosodium urate crystals.
  4. Diagnosis: Confirm gout diagnosis based on clinical presentation and fluid analysis; start treatment with NSAIDs and discuss lifestyle modifications.

Section 4: Seronegative Spondyloarthropathies

Seronegative spondyloarthropathies are a group of inflammatory arthritides that share some common features and include ankylosing spondylitis, psoriatic arthritis, and reactive arthritis among others. They are characterized by a negative rheumatoid factor and typically affect the spine and sacroiliac joints.

Key Features

  • Ankylosing Spondylitis: Involves chronic inflammation of the spine leading to eventual fusion of the vertebrae.
  • Psoriatic Arthritis: Associated with psoriasis and can cause both peripheral and axial joint issues.

Diagnosis

Diagnosis generally relies on clinical features, HLA-B27 testing, and imaging studies to show evidence of sacroiliitis.

Treatment

  • Treatment Options: Typically include NSAIDs for pain relief, physical therapy, and biologic agents for more severe disease.

Example: Case Study on Ankylosing Spondylitis

Case: A 28-year-old male presents with persistent lower back pain improving with activity and worsening with rest.

Step-by-Step Analysis:

  1. History: Document the history of symptoms, including the pattern of pain and any family history.
  2. Physical Examination: Assess spinal mobility and perform specific tests such as the Schober test to evaluate lumbar flexibility.
  3. Blood Tests: Order HLA-B27 test to assist in diagnosis.
  4. Imaging: Obtain MRI or X-ray to evaluate for sacroiliitis.
  5. Diagnosis: Confirm ankylosing spondylitis and initiate treatment with NSAIDs.

Section 5: Systemic Connective Tissue Diseases and Vasculitides

Systemic connective tissue diseases (CTD) encompass a range of disorders characterized by an overactive immune response affecting multiple systems in the body. Examples include systemic lupus erythematosus (SLE), scleroderma, and dermatomyositis. Vasculitides involve inflammation of blood vessels and can lead to organ damage.

Key Features

  • Systemic Lupus Erythematosus: Can involve skin, joints, kidneys, and other organs; characterized by a “butterfly rash” and systemic symptoms.
  • Vasculitis: Includes conditions such as granukomatosis with polyangiitis (Wegener's granulomatosis) which can affect multiple organ systems.

Diagnosis

Diagnosis of CTDs often involves a combination of clinical presentation, laboratory studies (e.g., antinuclear antibodies), and imaging as appropriate.

Treatment

  • Management strategies typically include immunosuppressive treatments such as corticosteroids and specific biologics aimed at controlling the disease activity.

Conclusion

Understanding arthritis and connective tissue diseases is crucial for effective diagnosis and management. This lesson has covered the main types of arthritis, their distinguishing features, treatments, and the pathophysiological basis. Recognizing the systemic impacts of connective tissue diseases and vasculitis is imperative for timely interventions and improving patient outcomes.

Study Notes

  • Osteoarthritis is primarily degenerative and often age-related.
  • Rheumatoid arthritis is autoimmune, commonly presenting bilaterally with morning stiffness.
  • Crystal arthropathies involve joint inflammation due to crystal deposits causing acute symptoms.
  • Seronegative spondyloarthropathies affect spinal joints and may involve younger patients.
  • Systemic connective tissue diseases can impact multiple organ systems and require tailored immunosuppressive therapy.

Practice Quiz

5 questions to test your understanding